(19)
(11) EP 2 358 684 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
22.10.2014 Bulletin 2014/43

(45) Mention of the grant of the patent:
06.08.2014 Bulletin 2014/32

(21) Application number: 08876356.0

(22) Date of filing: 20.10.2008
(51) International Patent Classification (IPC): 
C07D 401/06(2006.01)
C07D 239/91(2006.01)
 C07D 405/06(2006.01)
C07D 487/04(2006.01)
(86) International application number:
PCT/US2008/011958
(87) International publication number:
WO 2010/047674 (29.04.2010 Gazette 2010/17)

(54)

LOW MOLECULAR WEIGHT THYROID STIMULATING HORMONE RECEPTOR (TSHR) AGONISTS

SCHILDDRÜSEN-STIMULIERENDE HORMON (TSH) REZEPTOR AGONISTEN MIT ERINGEM MOLEKULARGEWICHT

AGONISTES DE FAIBLE POIDS MOLÉCULAIRE DU RÉCEPTEUR DE L HORMONE STIMULATRICE DE LA THYROÏDE (TSHR)

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

(43) Date of publication of application:
24.08.2011 Bulletin 2011/34

(73) Proprietors:
  • The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services
    Rockville, MD 20852-3804 (US)
  • Forschungsverbund Berlin e.V.
    12489 Berlin-Adlershof (DE)

(72) Inventors:
  • GERSHENGORN, Marvin, C.
    Washington DC 20008 (US)
  • NEUMANN, Susanne
    Bethesda MD 20814 (US)
  • RAAKA, Bruce, M.
    Rockville MD 20850 (US)
  • THOMAS, Craig, J.
    Gaithersburg MD 20878 (US)
  • INGLESE, James
    Bethesda MD 20817 (US)
  • SOUTHALL, Noel, T.
    Chevy Chase MD 20815 (US)
  • TITUS, Steven
    Elkridge MD 21075 (US)
  • ZHENG, Wei
    Potomac MD 20855 (US)
  • HUANG, Wenwei
    Rockville MD 20852 (US)
  • KRAUSE, Gerd
    13156 Berlin (DE)
  • KLEINAU, Gunnar
    13187 Berlin (DE)

(74) Representative: Couchman, Jonathan Hugh et al
HGF Limited Belgrave Hall Belgrave Street
Leeds LS2 8DD
Leeds LS2 8DD (GB)


(56) References cited: : 
WO-A-2008/153760
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).